Navigation Links
All Specialty Care Treatments Will Be Offered At Belle Vue.

In Kolkata Pradip Tandon the Chief of Belle Vue Clinic told the press that the clinic will be converted to a hospital by 2006.

In this project Rs 30 crores is invested to transform this // clinic into a 200 bed hospital with all the health care facilities.

A plastic surgery unit is also to be opened under the same roof with an investment of Rs 1 crore.

He emphasized on the growing demand for plastic surgery as they receive 15-20 cases/ month. Now due to the greater awareness among the people regarding beauty more and more want to go in for plastic surgery apart from reconstructive surgery.

The age group which opts for this is between 25-25 years with the cost depending on the type of treatment.

The clinic is basically very much interested in development of eye care specialties. In collaboration with the Aravind eye care hospital at Madurai, the hospital plans to provide the best eye care treatment in Kolkata.

The Aravind eye care hospital at Madurai is one of the best hospitals with respect to eye care treatments and surgeries. It is also the largest community eye care centre in the world.

The collaboration would facilitate to unite the best of both the hospitals.

The hospital plans to increase the number of operating theatres to ten equipped to do all types of surgeries.

Three theatres will be set aside especially for eye surgeries.

The clinic charges around 15,000 – 100000 per patient depending on the ailment.

It plans to conduct public workshops and seminars periodically to increase the awareness among the people about specialty health care treatments.


'"/>




Page: 1

Related medicine news :

1. Inhospitable Response Curtail Growth Of Specialty Hospitals: United States
2. Envisaged Specialty Training Programme For Junior Doctors Encounters a Speed Breaker
3. Reliance Group to Develop Specialty Blood Products
4. Vasan Group to Open Eight Specialty Eye Hospitals
5. New Gene Identification Help Asthma Treatments
6. Comparing Psoriasis Treatments
7. Effectiveness Of Infertility Treatments Questioned
8. Cancer Treatments Fall Short Of Targets
9. LASIK Treatments Still To Reach Common Man
10. Asian Alternative Treatments For Cancer On The Rise In Europe
11. Mobilizing Stem Cells at the Injured Site Using Hyperbaric Oxygen Treatments.
Post Your Comments:
Breaking Medicine Technology:Medco, State of Illinois and Community Retail Pharmacies Launch 'Wired' Collaborative Solution to Close Critical Medication-Related Gaps in Healthcare, Improving Outcomes and Lowering Costs 2Medco, State of Illinois and Community Retail Pharmacies Launch 'Wired' Collaborative Solution to Close Critical Medication-Related Gaps in Healthcare, Improving Outcomes and Lowering Costs 3Medco, State of Illinois and Community Retail Pharmacies Launch 'Wired' Collaborative Solution to Close Critical Medication-Related Gaps in Healthcare, Improving Outcomes and Lowering Costs 4Medco, State of Illinois and Community Retail Pharmacies Launch 'Wired' Collaborative Solution to Close Critical Medication-Related Gaps in Healthcare, Improving Outcomes and Lowering Costs 5FDA Launches Orphan Drug Workshop at KGI 2Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 2Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 3Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 4Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 5Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 6Researchers prolong the plasma half life of biopharmaceutical proteins 14192 1Researchers prolong the plasma half life of biopharmaceutical proteins 14192 2Pivotal Registration Trial of OPAXIO Maintenance Therapy in First Line Ovarian Cancer Reaches Enrollment Milestone of 600 patients Cell Therapeutics 5026 1Pivotal Registration Trial of OPAXIO Maintenance Therapy in First Line Ovarian Cancer Reaches Enrollment Milestone of 600 patients Cell Therapeutics 5026 2Pivotal Registration Trial of OPAXIO Maintenance Therapy in First Line Ovarian Cancer Reaches Enrollment Milestone of 600 patients Cell Therapeutics 5026 3Pivotal Registration Trial of OPAXIO Maintenance Therapy in First Line Ovarian Cancer Reaches Enrollment Milestone of 600 patients Cell Therapeutics 5026 4Fortebio Inc to Present at UBS Global Life Sciences Conference 14190 1